Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

INVA 11.90 -0.44 (-3.57%)
price chart
Stock Heading Lower Today: Innoviva, Inc. (:INVA)
Innoviva, Inc. (:INVA) was a top loser in today's session as the company saw shares drop -5.75% on the day at the time of writing.
What Wall Street is saying about Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA) is exchanging hands at $13.4 and lots of rating firms seem to have a target price set on the stock.
Worth Watching Stock: Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA) is expected to report Q1 earnings after market close (confirmed) on Thursday 04/28/2016. The company operates in the Application Software industry.
Innoviva meets 1Q profit forecasts  Money Morning
Innoviva: On Track To Buy Back The Whole Company
I have already reviewed the performance of GSK's (NYSE:GSK) new respiratory drugs in another article, so this one will focus on the issues specific to its development partner Innoviva (NASDAQ:INVA) (formerly called Theravance). Innoviva ended 2015 with ...
Trade-Ideas: Innoviva (INVA) Is Today's Weak On High Relative Volume Stock
INNOVIVA INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago.
Innoviva, Inc. (NASDAQ:INVA) To Report Earnings
Analysts await Innoviva, Inc. (NASDAQ:INVA) to report earnings on Apr, 28 for the fiscal quarter ending Mar 2016. They expect $0.09 EPS, up 200% or $0.18 from last year's $-0.09 per share.
Innoviva Inc (INVA) Upgraded by Zacks Investment Research to Buy
Innoviva Inc logo Zacks Investment Research upgraded shares of Innoviva Inc (NASDAQ:INVA) from a hold rating to a buy rating in a research note released on Wednesday, Market Beat.
Innoviva to Report First Quarter 2016 Financial Results on April 28  Marketwired (press release)
Innoviva Inc (INVA) Raised to "Buy" at Zacks Investment Research  Web Breaking News
Innoviva Inc (INVA) Downgraded to Hold at Zacks Investment Research
Innoviva Inc logo Zacks Investment Research cut shares of Innoviva Inc (NASDAQ:INVA) from a buy rating to a hold rating in a report published on Wednesday morning, MarketBeat.
Theravance (THRX) Changes Name, Ticker to Innoviva (INVA)
Theravance, Inc. (NASDAQ: THRX) announced that it changed its name to Innoviva, Inc., effective January 7, 2016. In addition to Innoviva's new name, the company has also unveiled a new corporate identity and website, available at www.
Innoviva Inc (INVA) Upgraded to "Buy" at Zacks Investment Research
Innoviva logo Innoviva Inc (NASDAQ:INVA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Tuesday, MarketBeat Ratings reports.
Innoviva Inc (INVA) Upgraded by Zacks Investment Research to "Buy"  South Florida Hedge Fund Managers